- cafead   Jul 08, 2024 at 11:52: AM
via A federal court last week ruled against Boehringer Ingelheim’s legal challenge to the Medicare Drug Price Negotiation Program, granting the Biden administration its latest victory over the pharma industry’s efforts to block the Inflation Reduction Act.
article source
article source